Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
Expert Opinion on Drug Discovery (2016) Vol. 12, Iss. 1, pp. 61-88
Closed Access | Times Cited: 398

Showing 1-25 of 398 citing articles:

Targeting Tumor Microenvironment for Cancer Therapy
Catarina Roma‐Rodrigues, Rita Mendes, Pedro V. Baptista, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 840-840
Open Access | Times Cited: 1024
In silico methods and tools for drug discovery
Bilal Shaker, Sajjad Ahmad, Jingyu Lee, et al.
Computers in Biology and Medicine (2021) Vol. 137, pp. 104851-104851
Closed Access | Times Cited: 383
Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one
Claudiu T. Supuran, Vincenzo Alterio, Anna Di Fiore, et al.
Medicinal Research Reviews (2018) Vol. 38, Iss. 6, pp. 1799-1836
Open Access | Times Cited: 234
Targeting Metalloenzymes for Therapeutic Intervention
Allie Y. Chen, Rebecca N. Adamek, Benjamin L. Dick, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1323-1455
Open Access | Times Cited: 232
Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors
Claudiu T. Supuran
Metabolites (2017) Vol. 7, Iss. 3, pp. 48-48
Open Access | Times Cited: 218
Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors
Claudiu T. Supuran
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 12, pp. 963-970
Closed Access | Times Cited: 217
Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
Chandra Bhushan Mishra, Manisha Tiwari, Claudiu T. Supuran
Medicinal Research Reviews (2020) Vol. 40, Iss. 6, pp. 2485-2565
Closed Access | Times Cited: 216
Benzothiazole derivatives as anticancer agents
Ali Irfan, Fozia Batool, Syeda Andleeb Zahra Naqvi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2019) Vol. 35, Iss. 1, pp. 265-279
Open Access | Times Cited: 205
An Overview of the Bacterial Carbonic Anhydrases
Claudiu T. Supuran, Clemente Capasso
Metabolites (2017) Vol. 7, Iss. 4, pp. 56-56
Open Access | Times Cited: 202
Carbonic Anhydrases and Metabolism
Claudiu T. Supuran
Metabolites (2018) Vol. 8, Iss. 2, pp. 25-25
Open Access | Times Cited: 183
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018)
Alessio Nocentini, Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 729-740
Closed Access | Times Cited: 182
Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 709-712
Open Access | Times Cited: 163
Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery
Alessio Nocentini, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 11, pp. 1175-1197
Closed Access | Times Cited: 147
Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment
Andrea Angeli, Fabrizio Carta, Alessio Nocentini, et al.
Metabolites (2020) Vol. 10, Iss. 10, pp. 412-412
Open Access | Times Cited: 141
Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
Alessio Nocentini, Andrea Angeli, Fabrizio Carta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 561-580
Open Access | Times Cited: 104
Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery
Clemente Capasso, Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 6, pp. 465-474
Closed Access | Times Cited: 17
Metal–ligand interactions in drug design
Laura Riccardi, Vito Genna, Marco De Vivo
Nature Reviews Chemistry (2018) Vol. 2, Iss. 7, pp. 100-112
Closed Access | Times Cited: 152
Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes
Kaan Küçükoğlu, Halise İnci Gül, Parham Taslımı, et al.
Bioorganic Chemistry (2019) Vol. 86, pp. 316-321
Closed Access | Times Cited: 139
Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
Fenil Shah, Derek P. Logsdon, Richard A. Messmann, et al.
npj Precision Oncology (2017) Vol. 1, Iss. 1
Open Access | Times Cited: 129
Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery
Claudiu T. Supuran
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 6, pp. 671-686
Closed Access | Times Cited: 115
Benzenesulfonamides Incorporating Flexible Triazole Moieties Are Highly Effective Carbonic Anhydrase Inhibitors: Synthesis and Kinetic, Crystallographic, Computational, and Intraocular Pressure Lowering Investigations
Alessio Nocentini, Marta Ferraroni, Fabrizio Carta, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 23, pp. 10692-10704
Closed Access | Times Cited: 101
Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 713-721
Closed Access | Times Cited: 101
Special Issue: Sulfonamides
Claudiu T. Supuran
Molecules (2017) Vol. 22, Iss. 10, pp. 1642-1642
Open Access | Times Cited: 100
Biomedical applications of prokaryotic carbonic anhydrases
Claudiu T. Supuran, Clemente Capasso
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 745-754
Closed Access | Times Cited: 98
Synthesis, characterisation, biological evaluation andin silicostudies of sulphonamide Schiff bases
Mustafa Durgun, Cüneyt Türkeş, Mesut Işık, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 950-962
Open Access | Times Cited: 97
Page 1 - Next Page

Scroll to top